X-134807614-A-G

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001388447.1(PABIR3):​c.16A>G​(p.Met6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000414 in 1,208,739 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.0000027 ( 0 hom. 1 hem. )

Consequence

PABIR3
NM_001388447.1 missense

Scores

2
1
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.64

Publications

0 publications found
Variant links:
Genes affected
PABIR3 (HGNC:25202): (PABIR family member 3) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11699957).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR3NM_001388447.1 linkc.16A>G p.Met6Val missense_variant Exon 2 of 11 ENST00000645433.2 NP_001375376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR3ENST00000645433.2 linkc.16A>G p.Met6Val missense_variant Exon 2 of 11 NM_001388447.1 ENSP00000496338.1 A0A2R8Y7S4

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111529
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000549
AC:
1
AN:
182060
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000763
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000273
AC:
3
AN:
1097157
Hom.:
0
Cov.:
30
AF XY:
0.00000276
AC XY:
1
AN XY:
362555
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26388
American (AMR)
AF:
0.00
AC:
0
AN:
35153
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19347
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30157
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53959
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40512
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4132
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841480
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46029
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111582
Hom.:
0
Cov.:
23
AF XY:
0.0000296
AC XY:
1
AN XY:
33800
show subpopulations
African (AFR)
AF:
0.0000651
AC:
2
AN:
30741
American (AMR)
AF:
0.00
AC:
0
AN:
10488
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3562
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2662
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6007
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53052
Other (OTH)
AF:
0.00
AC:
0
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 07, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.16A>G (p.M6V) alteration is located in exon 1 (coding exon 1) of the FAM122C gene. This alteration results from a A to G substitution at nucleotide position 16, causing the methionine (M) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
15
DANN
Benign
0.80
DEOGEN2
Benign
0.22
.;.;.;.;.;.;T;.;T;T;.;.
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.80
.;T;D;T;T;T;T;T;.;T;T;T
M_CAP
Benign
0.0059
T
MetaRNN
Benign
0.12
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
2.0
.;.;.;.;.;.;M;M;.;.;.;.
PhyloP100
1.6
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-3.9
.;.;D;.;.;.;D;D;.;.;.;.
REVEL
Benign
0.16
Sift
Pathogenic
0.0
.;.;D;.;.;.;D;D;.;.;.;.
Sift4G
Pathogenic
0.0
.;.;D;.;.;D;D;D;.;.;.;.
Polyphen
0.27, 0.52
.;.;.;.;.;.;B;P;.;.;.;.
Vest4
0.40, 0.41, 0.45, 0.33
MVP
0.54
MPC
0.21
ClinPred
0.49
T
GERP RS
2.0
PromoterAI
0.32
Neutral
Varity_R
0.71
gMVP
0.44
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201369085; hg19: chrX-133941644; API